Cargando…

Protective Effects of Thymoquinon on Pulmonary Disorders in Experimental Studies

Lung as vital organ is exposed to many injurious agents that can cause inflammation and oxidative stress, which are potential causes in the pathogenesis of lung diseases. Nigella sativa, usually introduced as black seed, has been considered for treatment of various diseases and is one the most widel...

Descripción completa

Detalles Bibliográficos
Autores principales: Noorbakhsh, Mohammad-Foad, Shaterzadeh-Yazdi, Hanieh, Hayati, Farzad, Samarghandian, Saeed, Farkhondeh, Tahereh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Research Institute of Tuberculosis and Lung Disease 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534803/
https://www.ncbi.nlm.nih.gov/pubmed/31143211
_version_ 1783421482869719040
author Noorbakhsh, Mohammad-Foad
Shaterzadeh-Yazdi, Hanieh
Hayati, Farzad
Samarghandian, Saeed
Farkhondeh, Tahereh
author_facet Noorbakhsh, Mohammad-Foad
Shaterzadeh-Yazdi, Hanieh
Hayati, Farzad
Samarghandian, Saeed
Farkhondeh, Tahereh
author_sort Noorbakhsh, Mohammad-Foad
collection PubMed
description Lung as vital organ is exposed to many injurious agents that can cause inflammation and oxidative stress, which are potential causes in the pathogenesis of lung diseases. Nigella sativa, usually introduced as black seed, has been considered for treatment of various diseases and is one the most widely investigated herbs. Thymoquinone (TQ) is the major component of the volatile oil of black seed (54%) which has been indicated to anti-oxidant, anti-inflammatory and anti-neoplastic properties. There is interesting to study on TQ effect as a therapeutic agent for various diseases in both in vivo and in vitro conditions. In this comprehensive review, we summarized the recent studies related to the effectiveness of TQ on lung disorders such as inflammatory lung diseases, lung fibrosis, asthma and lung cancer. It is concluded that TQ with anti-inflammatory, anti- oxidant, anti-asthmatic and anti- tumor activity can provide therapeutic effects against lung disorders. However, more investigation is needed to produce TQ as a pharmaceutical preparation for human studies.
format Online
Article
Text
id pubmed-6534803
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher National Research Institute of Tuberculosis and Lung Disease
record_format MEDLINE/PubMed
spelling pubmed-65348032019-05-29 Protective Effects of Thymoquinon on Pulmonary Disorders in Experimental Studies Noorbakhsh, Mohammad-Foad Shaterzadeh-Yazdi, Hanieh Hayati, Farzad Samarghandian, Saeed Farkhondeh, Tahereh Tanaffos Review Article Lung as vital organ is exposed to many injurious agents that can cause inflammation and oxidative stress, which are potential causes in the pathogenesis of lung diseases. Nigella sativa, usually introduced as black seed, has been considered for treatment of various diseases and is one the most widely investigated herbs. Thymoquinone (TQ) is the major component of the volatile oil of black seed (54%) which has been indicated to anti-oxidant, anti-inflammatory and anti-neoplastic properties. There is interesting to study on TQ effect as a therapeutic agent for various diseases in both in vivo and in vitro conditions. In this comprehensive review, we summarized the recent studies related to the effectiveness of TQ on lung disorders such as inflammatory lung diseases, lung fibrosis, asthma and lung cancer. It is concluded that TQ with anti-inflammatory, anti- oxidant, anti-asthmatic and anti- tumor activity can provide therapeutic effects against lung disorders. However, more investigation is needed to produce TQ as a pharmaceutical preparation for human studies. National Research Institute of Tuberculosis and Lung Disease 2018-10 /pmc/articles/PMC6534803/ /pubmed/31143211 Text en Copyright© 2018 National Research Institute of Tuberculosis and Lung Disease http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Noorbakhsh, Mohammad-Foad
Shaterzadeh-Yazdi, Hanieh
Hayati, Farzad
Samarghandian, Saeed
Farkhondeh, Tahereh
Protective Effects of Thymoquinon on Pulmonary Disorders in Experimental Studies
title Protective Effects of Thymoquinon on Pulmonary Disorders in Experimental Studies
title_full Protective Effects of Thymoquinon on Pulmonary Disorders in Experimental Studies
title_fullStr Protective Effects of Thymoquinon on Pulmonary Disorders in Experimental Studies
title_full_unstemmed Protective Effects of Thymoquinon on Pulmonary Disorders in Experimental Studies
title_short Protective Effects of Thymoquinon on Pulmonary Disorders in Experimental Studies
title_sort protective effects of thymoquinon on pulmonary disorders in experimental studies
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534803/
https://www.ncbi.nlm.nih.gov/pubmed/31143211
work_keys_str_mv AT noorbakhshmohammadfoad protectiveeffectsofthymoquinononpulmonarydisordersinexperimentalstudies
AT shaterzadehyazdihanieh protectiveeffectsofthymoquinononpulmonarydisordersinexperimentalstudies
AT hayatifarzad protectiveeffectsofthymoquinononpulmonarydisordersinexperimentalstudies
AT samarghandiansaeed protectiveeffectsofthymoquinononpulmonarydisordersinexperimentalstudies
AT farkhondehtahereh protectiveeffectsofthymoquinononpulmonarydisordersinexperimentalstudies